ArticleJHEP reports : innovation in hepatology2026
Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4α.
Xinru Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.